Secondary malignant tumors of the female genital tract

Česká verzia

Authors: Luboš Minář ¹ ; Vít Weinberger ¹ ; E. Jandáková ²
Authors place of work: Gynekologicko-porodnická klinika LF MU a FN Brno, přednosta prof. MUDr. P. Ventruba, DrSc. ¹; Ústav patologie LF MU a FN Brno, přednosta doc. MUDr. J. Feit, CSc. ²
Published in the journal: Ceska Gynekol 2010; 75(6): 535-539

Summary

Objective:
Information sheet about metastatic tumors of the female genital tract.

Design:
Literature review with case reports.

Setting:
Department of Gynaecology and Obstetrics, Faculty of Medicine, Masaryk’s University and Fakulty Hospital, Brno.

Methods:
Literature review about metastatic tumors of the female genital tract with illustrative case reports.

Conclusions:
Secondary gynecological malignant tumors are much less common than primary tumors of the female genital tract with the exception cancer of the fallopian tube and the vagina. Primary malignant tumors of the fallopian tube and the vagina are rare, the primary location of the tumor usually is in other areas of the female genital tract and the tumor grows directly into the above-mentioned organs secondarily. There is talking about metastatic malignant tumors of the female genital tract in the strict sense in the case of extragenital primary origin the cancer. Metastases can be caused by direct penetration of the tumor from anatomically adjacent organs, particularly from the bladder and the rectum, or are going through the lymph or the blood vessels. The most common primary location of the tumor are the breast, the stomach and the bowel in this case. Secondary laesions of the female genital tract can be sometimes the first clinical manifestation of the primary extragenital malignant tumor, simultaneously represent clearly negative prognostic factor for the disease. Differential diagnostic algorithm for solving the secondary laesions of the female genital tract requires a multidisciplinary approach and cooperation with the pathologist and the clinical oncologist. Surgical treatment, the indication and extent based on adequately performed staging, is essential for the diagnosis of the primary tumor and is necessary as the palliative treatment for the elimination event. clinical symptoms and for the improving quality of the life.

Key words:
gynecological malignant tumors, metastasis, breast cancer, lymphoma, axilla dissection, hysterectomy.

Zdroje

1. Acikalin, MF., Oner, U., Tekin, B., et al. Metastasis from breast carcinoma to a tamoxifen-related endometrial polyp. Gynecol Oncol, 2005, 97, 3, p. 946-948.

2. Bogliolo, S., Morotti, M., Valenzano Menada, M., et al. Breast cancer with synchronous massive metastasis in the uterine cervix: a case report and review of the literature. Arch Gynecol Obstet, 2010, 281, 4, p. 769-773.

3. Fambrini, M., Andersson, KL., Buccoliero, AM. et al. Late solitary metastasis of cutaneous malignant melanoma presenting as abnormal uterine bleeding. J Obstet Gynaecol Res, 2008, 34, 2, p. 731-734.

4. Gabril, MY., Yousef, GM. Salivary duct carcinoma presenting with vaginal metastasis: case report. Eur J Gynaecol Oncol, 2007, 28, 5, p. 415-417.

5. Glaubitz, M., Jantzen, K., Amthor, M. Uterine metastases of malignant melanoma. Geburtshilfe Frauenheilkd, 1992, 52, 2, S. 92-95.

6. Hepp, HH., Hoos, A., Leppien, G., et al. Breast cancer metastatic to the uterine cervix: analysis of rare event. Cancer Invest, 1999, 17, 7, p. 468-473.

7. Jain, V., Gupta, K., Kudva, R., et al. A case of ovarian metastasis of gall bladder carcinoma simulating primary ovarian neoplasm: diagnostic pitfalls and review of literature. Int J Gynecol Cancer, 2006, 16 (Supp l1), p. 319-321.

8. Kang, LC., Thomas, DB., Wang, J., et al. Plasma cell myeloma presenting as abnormal uterine bleeding. Int J Gynecol Pathol, 2007, 26, 2, p. 130-132.

9. Kang, WD., Kim, C., Cho, MK., et al. Hepatocellular carcinoma presenting as uterine metastasis. Cancer Res Treat, 2008, 40, 3, p. 141-144.

10. Kir, G., Kir, M., Karateke, A., et al. Uterine metastases of extragenital carcinomas. Eur J Gynaecol Oncol, 2004, 25, 3, p. 387-388.

11. Kumar, NB., Hart, WR. Metastases to the uterine corpus from extragenital cancers. A clinicopathologic study of 63 cases. Cancer, 1982, 50, 10, p. 2163-2169.

12. Mrad, K., Morice, P., Fabre, A., et al. Krukenberg tumor: a clinico-pathological study of 15 cases. Ann Pathol, 2000, 20, 3, p. 202-206.

13. Nair, RR., Conroy, MD., Jeyarajah, AR. Obstructive uropathy secondary to parametrial metastasis: an unusual presentation of breast carcinoma. Eur J Gynaecol Oncol, 2009, 30, 2, p. 214-215.

14. Novotvary 2006 ČR, ÚZIS a NOR ČR 2009.

15. Pauer, HU., Viereck, V., Burfeind, P., et al. Uterine cervical metastasis of breast cancer: a rare complication that may be overlooked. Onkologie, 2003, 26, 1, p. 58-60.

16. Piura, B., Yanai-Inbar, I., Rabinovich, A., et al. Abnormal uterine bleeding as a presenting sign of metastases to the uterine corpus, cervix and vagina in a breast cancer patient on tamoxifen therapy. Eur J Obstet Gynecol Reprod Biol, 1999, 83, 1, p. 57-61.

17. Turan, T., Aykan, B., Koc, S., et al. Analysis of metastatic ovarian tumors from extragenital primary sites. Tumori, 2006, 92, 6, p. 491-495.

18. Yada-Hashimoto, N., Yamamoto, T., Kamiura, S., et al. Metastatic ovarian tumors: rewiew of 64 cases. Gynecol Oncol, 2003, 89, 2, p. 314-317.

19. Zafrakas, M., Papanicolau, AN., Venizelos, ID., et al. A rare case of renal cell carcinoma metastasizing to the uterine cervix. Eur J Gynaecol Oncol, 2009, 30, 2, s. 239-240.